IDH -wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification

Archive ouverte

Berzero, Giulia | Di Stefano, Anna Luisa | Ronchi, Susanna | Bielle, Franck | Villa, Chiara | Guillerm, Erell | Capelle, Laurent | Mathon, Bertrand | Laurenge, Alice | Giry, Marine | Schmitt, Yohann | Marie, Yannick | Idbaih, Ahmed | Hoang-Xuan, Khe | Delattre, Jean-Yves | Mokhtari, Karima | Sanson, Marc

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Abstract Background Isocitrate dehydrogenase (IDH) wildtype (wt) grade II gliomas are a rare and heterogeneous entity. Survival and prognostic factors are poorly defined. Methods We searched retrospectively all patients diagnosed with diffuse World Health Organization (WHO) grades II and III gliomas at our center (1989–2020). Results Out of 517 grade II gliomas, 47 were “diffuse astrocytomas, IDHwt.” Tumors frequently had fronto-temporo-insular location (28/47, 60%) and infiltrative behavior. We found telomerase reverse transcriptase (TERT) promoter mutations (23/45, 51%), whole chromosome 7 gains (10/37, 27%), whole chromosome 10 losses (10/41, 24%), and EGFR amplifications (4/43, 9%), but no TP53 mutations (0/22, 0%). Median overall survival (OS) was 59 months (vs 19 mo for IDHwt grade III gliomas) (P < 0.0001). Twenty-nine patients (29/43, 67%) met the definition of molecular glioblastoma according to cIMPACT-NOW update 3. Median OS in this subset was 42 months, which was shorter compared with patients with IDHwt grade II gliomas not meeting this definition (median OS: 57 mo), but substantially longer compared with IDHwt grade III gliomas meeting the definition for molecular glioblastoma (median OS: 17 mo, P < 0.0001). Most patients with IDHwt grade II gliomas met cIMPACT criteria because of isolated TERT promoter mutations (16/26, 62%), which were not predictive of poor outcome (median OS: 88 mo). Actionable targets, including 5 gene fusions involving FGFR3, were found in 7 patients (24%). Conclusions Our findings highlight the importance of histological grading and molecular profiling for the prognostic stratification of IDHwt gliomas and suggest some caution when assimilating IDHwt grade II gliomas to molecular glioblastomas, especially those with isolated TERT promoter mutation.

Consulter en ligne

Suggestions

Du même auteur

FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas

Archive ouverte | Picca, Alberto | CCSD

International audience. OBJECTIVE : To characterize the prevalence and prognostic significance of major driver molecular alterations in adult midline diffuse gliomas (MLG).METHODS : Adults with histologically proven...

Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions

Archive ouverte | Di Stefano, Anna Luisa | CCSD

International audience. Abstract Background Actionable fibroblast growth factor receptor 3 (FGFR3)–transforming acidic coiled-coil protein 3 fusions (F3T3) are found in approximately 3% of gliomas, but their charact...

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma

Archive ouverte | Seyve, Antoine | CCSD

International audience. Objective: IDH wild-type glioblastoma is the most common and aggressive primary brain cancer in adults. At tumor recurrence, treatment decision-making is not standardized; several options inc...

Chargement des enrichissements...